
A renowned researcher in the field of cardiac catheterization and heart attack treatment, Dr. Reiner is the director of the Cardiac Catheterization Laboratory at The George Washington University Hospital. He also serves as professor of Medicine in GW’s School of Medicine and Health Sciences, is a fellow of the American College of Cardiology, and maintains membership with the American Heart Association.
Dr. Reiner has garnered much recognition for his research. He has participated in many cardiovascular care studies and clinical trials including the “Enoxaparin in Unstable Angina (ESSENCE) Trial” in 1996, when he served as the principal investigator. He is currently serving as the principal investigator in a number of studies including the “CAMELOT Trial”, for the “Comparison of Amlodipine versus Enalapril to Limit Occurrence of Thrombosis” and the “Synergy Trial” for examining a new, early invasive treatment for myocardial infarction. Based on his research, Dr. Reiner has contributed articles to many journals including Circulation and the Journal of American College of Cardiology. In addition, he has presented his research at many national medical conferences including those sponsored by the American Heart Association and the American College of Cardiology. In 1993 he was the recipient of the Squibb/Society for Cardiac Angiography and Intervention Fellowship for Research in Cardiac Imaging.
A graduate of Georgetown University, Dr. Reiner performed his chief residency in medicine at Cornell University Medical College in New York. He began a fellowship in cardiology at The George Washington University Medical Center in 1990. In 1993, he completed a fellowship in interventional cardiology, which remains his focus today.